Market Overview:

The global airway management devices market size reached US$ 1.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2027, exhibiting a growth rate (CAGR) of 7.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Airway management devices are utilized for maintaining or restoring ventilation in a patient. It also involves evaluating, planning, and using different medical procedures to treat patients with respiratory failures or acute obstruction. Besides this, it protects the lungs from injury and provides gas exchange facilities to the patients. Some of the commonly used airway management devices to keep the upper airway open for offering unobstructed ventilation are supraglottic airway devices (SADs), tracheal intubation, transtracheal access, airway clearance.

Airway Management Devices Market Trends:

The increasing prevalence of respiratory diseases represents one of the key factors driving the market. Additionally, on account of the growing number of surgeries, there is a rise in the utilization of anesthesia. This, in confluence with numerous benefits of airway management devices, such as the high efficiency in airway clearance and maintenance of proper ventilation and patient safety during operative procedures, is also contributing to the market growth. Besides this, an increase in the emergency treatment of prolonged illness and protracted treatment associated with lung diseases in children and adults is catalyzing the demand for airway management devices. Furthermore, the advent of advanced techniques for preoperative airway evaluation is also strengthening the market growth. For instance, Preoperative Endoscopic Airway Evaluation (PEAE) is a technique that identifies, predicts the blocked ventilation, and facilitates a plan for efficient management, which particularly involves the usage of advanced devices, such as supraglottic airway. These airway devices provide easy tracheal placement resulting in improved patient safety, and are subsequently utilized in a range of clinical applications.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global airway management devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, patient type, application and end use.

Breakup by Product:

• Supraglottic Devices
  • Oropharyngeal Devices
  • Naspharyngeal Devices
  • Laryngeal Airway Devices
  • Others
• Infraglottic Devices
  • Endotracheal Tubes
  • Tracheostomy Tubes
  • Others
• Resuscitators
• Laryngoscopes
• Others
   

Breakup by Patient Type:

• Adult
• Pediatric Patient/Neonates
   

Breakup by Application:

• Anesthesia
• Emergency Medicine
• Others
   

Breakup by End Use:

• Hospitals
• Homecare
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ambu A/S, Armstrong Medical Ltd., Becton Dickinson and Company, Flexicare (Group) Limited, Intersurgical Ltd., Medline Industries Inc, Medtronic plc, Mercury Enterprises Inc., Smiths Group plc, Teleflex Incorporated, VBM Medizintechnik GmbH and Verathon Inc. (Roper Technologies Inc.).

Report Coverage: